Advocates embrace potential for ‘systemic changes’ stemming from House committee report on health and IP, but opponents question study’s ‘premise’

Some members of the pharmaceutical industry have argued throughout the COVID-19 pandemic that intellectual property is not the primary cause for global vaccine inequity.

Now that a House of Commons committee has issued a report on vaccine equity and intellectual property, the federal government will have 120 days to table a response to key recommendations, such as the possible extension of an IP waiver related to COVID-19. Trade Minister Mary Ng has previously kept the door open to supporting an extension of the waiver, but has not committed to it.The Hill Times photograph by Andrew Meade

Feature

BY IAN CAMPBELL

November 2, 2022

Advocates for reducing intellectual property rules to promote access to medicines see a report issued by the House Foreign Affairs Committee last week as having many positive elements, while members of the pharmaceutical industry and related groups expressed mixed reactions, ranging from openness de...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Today’s Headlines Newsletter

Your quick scan of the news you need each weekday to be the smartest person in the room.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy